Chambre Blue @ (The Blue Room)

Battle Cry 2024! Being AWAKE...means the end of passivity. If you want to take back our country & the American way of Life...fight for Freedom and Democracy!

[Elise Stefanik @EliseStefanik]

This is an issue I have long championed as a leader on the House Education Committee. Great partnership with @EDSecMcMahon !

[Elise Stefanik @EliseStefanik]

One year ago, when whistleblowers first revealed that special counsel Jack Smith and the FBI had targeted Republican senators in a highly secretive and unconstitutional spying operation, I immediately picked up the phone and called my close friend and colleague @Jim_Jordan .

“Jim, there is no way that we weren’t spied on,” I said. “There’s a larger list and my hunch is that we’re both on it.”

My hunch was correct.

READ my full @NYPostOpinion oped below👇

[U.S. Department of Education @usedgov]

$7.8M
$20.9M
$9.78M

Millions from Chinese military-linked entities have flowed to U.S. universities.

Past admins let reporting of counterparties slide, but no longer. As of today, entities posing real national security risks are fully visible on https://t.co/Xk7q6xlByi.

[Chambre Blue @ (The Blue Room) @ChambreBlue]

https://t.co/fbTRt5pYA2 via @YouTube

[Chambre Blue @ (The Blue Room) @ChambreBlue]

Crowning the New King of Supplements for 2026 https://t.co/qmhEXyDlcN via @YouTube

[Chambre Blue @ (The Blue Room) @ChambreBlue]

https://t.co/2JJXsY09Dk

[Amazing Nature @AmazingNature00]

Sometimes, a small act of kindness can change an entire life 💖

[Chambre Blue @ (The Blue Room) @ChambreBlue]

You were lied to about belly fat! https://t.co/DBjXaB6CK5 via @YouTube

[Chambre Blue @ (The Blue Room) @ChambreBlue]

Learn from England, America… https://t.co/hbR2CHcTGQ

[Buitengebieden @buitengebieden]

This reunion.. 😊

[Sassafrass84 @Sassafrass_84]

Funny how that works. Isn't it?¿ 🤔

[Ed @outerbanks1607]

The dog was scared something happened -- >> And for those that think DOGs don't grieve . read this and research it if you are A Non believer -- Allowing a dog to see their deceased owner's body is a common recommendation by hospice nurses and pet behaviorists. Experts and users agree this gives them vital closure, helping them understand you didn't abandon them and preventing prolonged waiting, anxiety, or searching behaviors.Dogs are incredibly intuitive and use smell to process the world. When they see and smell that a loved one has passed, their primal instincts help them grasp what has happened. Without this moment of goodbye, a dog might be left waiting for your return, which can cause significant emotional distress as they process an unexpected absence

[Chambre Blue @ (The Blue Room) @ChambreBlue]

Freudian slip…

[Mario Nawfal @MarioNawfal]

🇺🇸 If this isn’t one of the most ‘Murica’ things you’ve ever seen!

A bald eagle flying off to the U.S. National Anthem.

🎂 Happy 250th Birthday, America!

Writer: Jamie

[Chambre Blue @ (The Blue Room) @ChambreBlue]

Why I'm using Methylene Blue for my metabolism https://t.co/oPaRmYm3Jn via @YouTube

[Pat Adams @PatAdams96]

Media: “They’re not communists!”

Democrats: “We’re communists.”

[Chambre Blue @ (The Blue Room) @ChambreBlue]

Check out Gov Newsom’s devil worshipping son.
Gavin Newsom PANICS Over DOJ Investigations into MONEY LAUNDERING & ELEC... https://t.co/roXSvNaaWE via @YouTube

[Chambre Blue @ (The Blue Room) @ChambreBlue]

After watching this amazing YouTube video about 3 men being killed by sharks recently in Australia, I found this GoFundMe, for the widow and 2 girls, the youngest only 4 months. Their family is facing an unimaginable loss after Steven's sudden passing. They need our support to navigate this difficult time. Please consider donating or sharing to help Shirene and her daughters find some relief. Every bit counts in this moment of grief. https://t.co/WUzr6qElme

[Nature Unedited @NatureUnedited]

When rabbits feel safe with a companion, they often rest very close, groom each other and even sleep partially on top of one another

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson